Search Thermo Fisher Scientific
Celebrating 40 Years of Applied Biosystems
Browse interviews with scientists from all over the world who have used Applied Biosystems solutions to lay the groundwork for their history-defining breakthroughs, as well as the rising stars who are pushing the boundaries and tackling some of the most important unanswered questions facing genomics.
Cancer research
Deepak Mishra, Sushant
Vinarkar, Mayur Parihar
Tata Medical Center, Kolkata
Dr. Col. Deepak Mishra and his team of researchers share how Applied Biosystems technologies enable their research on acute leukemias.
Kristi Baker, PhD
Associate Professor
University of Alberta
Dr. Kristi Baker shares how her lab uses both animal and human models for their research into colon cancer, in order to close the gap between bench and bedside.
Francis Barany, PhD
Professor, Microbiology
Weill Cornell Medicine
Dr. Barany is researching new liquid biopsy methods using cost efficient and scalable technology, in order to make cancer detection more accessible.
Anuradha Chougule
Consultant, Tata Memorial Hospital
Professor, MUHS
Professor Anuradha Chougule is working to develop targeted, affordable cancer therapies that avoid the harmful side effects of chemotherapy.
Dr. Atocha Romero
Director, Liquid Biopsy Laboratory
Hospital Universitario Puerta di Hierro
Dr. Romero discusses the potential of liquid biopsy as a tool in the fight against lung cancer.
Derek McMahon, PhD
Postdoctoral Fellow
University of Pennsylvania
Derek explains how bitter compounds have the potential to act as therapies for multiple diseases, including cancer.
Shimon Sakaguchi, MD, PhD
Immunology Frontier Research Center Osaka University
Professor Sakaguchi became fascinated by the immune system early in his career. His drive and curiosity led him to the discovery of Treg cells and their role in autoimmunity.
Lanbo Xiao
Research Investigator
University of Michigan
Meet Lanbo Xiao, a researcher using TaqMan Gene Expression analysis to differentiate between aggressive and non aggressive prostate cancer.
Sheri Olson
Senior Director, Product Management
Thermo Fisher Scientific
Meet Sheri Olson, and learn about her journey from a curious kid to one of the history-making scientists who studied and patented the BRCA1 breast cancer gene.
eBook: Learn how cutting edge genetic technologies are used to find the molecular drivers of cancer
Efrem Lim, PhD
Associate Professor, Biodesign Institute
Arizona State University
Efrem Lim shares how the QuantStudio™Absolute Q™Digital PCR System allows his lab to target mutations in SARS-Cov-2.
Veron Ramsuran
Profesor, Genetics
University of KwaZulu-Natal
Professor Ramsuran is using epigenetics to learn more about what makes certain people more susceptible to infectious diseases such as HIV and SARS-CoV-2.
Aayushi Uberoi, PhD
Postdoctoral Fellow
University of Pennsylvania
Aayushi Uberoi is exploring the new frontier of the skin microbiome, and its potential for preventing the spread of infections.
Dr. Sinaye Ngcapu
Senior Scientist
CAPRISA
Dr. Sinaye Ngcapu is studying the link between vaginal microbiota and HIV infection, in order to help reduce rates of HIV in South African women.
Gúbio Soares
Virologist
Federal University of Bahia
The first scientist to identify the Zika virus in Brazil, Gúbio Soares discusses his journey to the forefront of virology in his home country.
Dr. Satish Pillai
Senior Investigator, Vitalant Research Institute
Professor, UCSF
Dr. Pillai is trying to unravel some of the biggest challenges still facing researchers when it comes to developing a cure for HIV.
Luther King Abia Akebe
Professor, Applied & Environmental Microbiology
University of KwaZulu-Natal
Professor Abia Akebe wants to close the loop in understanding how infections are passed between the environment, animals and humans.
Nikolaos Mellios, MD, PhD
Associate Professor
University of New Mexico
Professor Mellios shares how his research into circular RNA can help answer questions about psychiatric and neurological disorders such as bipolar disorder and schizophrenia.
Diana Mechtcheriakova, PhD
Anastasia Meshcheryakova, PhD
Medical University of Vienna
Learn about the mother-daughter research team working to decipher the complexity of multi-factorial diseases.
Peter Böhm
Chief Biomedical Laboratory Scientist
Rigshospitalet
Peter Böhm talks technology evolution, from the Applied Biosystems SeqStudio Flex™ to the QuantStudio™ Absolute Q™ dPCR System.
Maristella Donato
PhD Candidate, Pharmacological Sciences University of Padua / University of Washington
Maristella Donato’s research uses TaqMan gene expression assays to understand the linkage between diabetes and cardiovascular disease.
Quinton Smith, PhD
Assistant Professor
University of California, Irvine
Quinton Smith talks about how his engineering based approach to stem cell research has implications for conditions such as end stage liver disease
Joanna Williams, PhD
Associate Professor
University of Otago
Professor Joanna Williams' lab hopes to identify early markers of Alzheimer's disease using TaqMan microfluidic arrays.
Sir Peter Donnelly, FRS, FMEDSCI
Founder & CEO, Genomics plc
Sir Peter Donnelly discusses the implications, challenges, and potential for integrating polygenic risk scores into standard healthcare practices around the world.
Radja Badji, PhD
Genome Operations Manager
Qatar Genome Programme
Radja Badji explains how her team is using custom microarray technology to bring the benefits of precision medicine to the Arab world.
Richard Pither, PhD
CEO, Cytox
Richard Pither and his company, Cytox, are utilizing polygenic risk scores to develop tests that might accurately identify a person's risk of developing Alzheimer's disease.
Philip Empey, PharmD, PhD
Assistant Professor, Associate Director
Pitt/UPMC Institute of Precision Medicine
Learn how microarray technologies enable Philip Empey perform broad based genotyping, in an effort to understand more about drug variability.
Pui Kwok, MD, PhD
Professor, UCSF
Director, Institute of Biomedical Sciences, Academia Sinica
Pui Kwok discusses the Taiwan Precision Medicine Initiative, and the opportunities an challenges of integrating precision medicine into standard healthcare.
Ulrich Broeckel, MD
Founder and CEO
RPRD Diagnostics, LLC
Dr. Broeckel shares his vision for the future of pharmacogenetics, and how its integration with precision medicine approaches can impact clinical care
Jeanette Schmidt
Head of Bioinformatics
Thermo Fisher Scientific
“What we do matters so much.” Jeanette Schmidt explains how being able to collaborate with customers and help them answer their research questions inspires her work in bioinformatics.
Timothy R. Rebbeck, PhD
Dana Farber Cancer Institute
Harvard TH Chan School of Public Health
As leader of the MADCaP Network, Timothy Rebbeck uses custom Axiom Genotyping Solutions to address outcome disparities for prostate cancer.
White paper: Navigating the technology landscape for population scale predictive genomics
Amy Coslik
Animal Projects Coordinator
Fort Worth Zoo
Learn how Amy Coslik is working with Thermo Fisher Scientific to help protect the health and safety of the elephants living at the Fort Worth Zoo.
Gregory O’Corry Crowe, PhD
Research Professor
Harbor Branch Oceanographic
Institute, FAU
Professor O’Corry Crowe discusses how his team uses capillary electrophoresis techniques to tackle Arctic mammal conservation.
For Research Use Only. Not for use in diagnostic procedures.
Style Sheet for Global Design System
Style Sheet for Komodo Tabs